Ab00147-1.1-VPS
| Anti-IL-4 [11B11]
| 25 mg
| Absolute Antibody
| ELISA; FC; in vivo; IHC
|
|
| Mouse
| Request Quotation
| Request
|
Ab00124-8.1
| Anti-CD52 [Alemtuzumab (Campath-1H)]
| 200 ug
| Absolute Antibody
| Cytotoxicity Assay; ELISA; IHC-Fr; IHC-P; in vivo;
|
|
| Human; Rhesus Monkey; Cynomolgus Monkey
| Request Quotation
| Request
|
Ab00735-10.6-BT
| Anti-ADAMts13 [1-420 scFv]
| 500 ug
| Absolute Antibody
| Inhibit
|
|
| Human; Mouse
| Request Quotation
| Request
|
Ab00135-9.1-BT
| Anti-Beta-galactosidase [13R4]
| 1 mg
| Absolute Antibody
| WB; FC; negative control
|
|
| E. Coli
| Request Quotation
| Request
|
Ab00135-1.1
| Anti-Beta-galactosidase [13R4]
| 200 ug
| Absolute Antibody
| WB; FC; negative control
|
|
| E. Coli
| Request Quotation
| Request
|
Ab00116-10.0-BT
| Anti-Polyethylene Glycol [E11]
| 500 ug
| Absolute Antibody
| ELISA; WB; FC
|
|
| n/a
| Request Quotation
| Request
|
Ab00137-23.0
| Anti-Insulin Receptor alpha [83-14]
| 200 ug
| Absolute Antibody
| ELISA; IF; IP; WB; IHC
|
|
| Human; Bovine; Pig; Sheep
| Request Quotation
| Request
|
Ab00112-23.0
| Anti-CD3 epsilon [UCHT1]
| 200 ug
| Absolute Antibody
| FC; IHC
|
|
| Human
| Request Quotation
| Request
|
Ab00141-23.0-BT
| Anti-Lipopolysaccharide [WN1 222-5]
| 1 mg
| Absolute Antibody
| WB; IHC-P
|
|
| Gram-negative bacteria
| Request Quotation
| Request
|
Ab00134-1.1-VPB
| Anti-EGFR [7A7]
| 100 mg
| Absolute Antibody
| IHC; in vivo; FC; IF
|
|
| Human; Mouse
| Request Quotation
| Request
|
Ab00141-23.0
| Anti-Lipopolysaccharide [WN1 222-5]
| 200 ug
| Absolute Antibody
| WB; IHC-P
|
|
| Gram-negative bacteria
| Request Quotation
| Request
|
Ab00123-8.1-VPB
| Anti-CD16/CD32 [2.4G2]
| 100 mg
| Absolute Antibody
| FC; IF; IP; IHC; Block
|
|
| Mouse
| Request Quotation
| Request
|
Ab00111-6.1-VPT
| Anti-CD200R [OX131]
| 10 mg
| Absolute Antibody
| FC
|
|
| Mouse
| Request Quotation
| Request
|
Ab00126-2.0
| Anti-CD20 [10F381 (rituximab)]
| 200 ug
| Absolute Antibody
| FC
|
|
| Human; Rhesus Monkey; Cynomolgus Monkey
| Request Quotation
| Request
|
Ab00126-26.0-BT
| Anti-CD20 [10F381 (rituximab)]
| 1 mg
| Absolute Antibody
| FC
|
|
| Human; Rhesus Monkey; Cynomolgus Monkey
| Request Quotation
| Request
|
Ab00387-1.4-BT
| Anti-A2A-Adenosine Receptor [Ig2838]
| 1 mg
| Absolute Antibody
| ELISA; Blocking
|
|
| Human
| Request Quotation
| Request
|
Ab00135-10.0
| Anti-Beta-galactosidase [13R4]
| 200 ug
| Absolute Antibody
| WB; FC; negative control
|
|
| E. Coli
| Request Quotation
| Request
|
Ab00124-35.0-BT
| Anti-CD52 [Alemtuzumab (Campath-1H)]
| 1 mg
| Absolute Antibody
| Cytotoxicity Assay; ELISA; IHC-Fr; IHC-P; in vivo;
|
|
| Human; Rhesus Monkey; Cynomolgus Monkey
| Request Quotation
| Request
|
Ab00136-10.0
| Anti-V5 epitope tag [SV5-P-K]
| 200 ug
| Absolute Antibody
| ELISA; IF; IHC-Fr; IP; RIA; WB
|
|
| Paramyxovirus Simian Virus 5
| Request Quotation
| Request
|
Ab01111-10.3-BT
| Anti-Almond Allergen [X151]
| 1 mg
| Absolute Antibody
| ELISA
|
|
| Prunus dulcis (Amygdalus dulcis; Almond)
| Request Quotation
| Request
|
Ab00121-23.0
| Anti-CD3 epsilon [500A2]
| 200 ug
| Absolute Antibody
| FC; Activate
|
|
| Mouse
| Request Quotation
| Request
|
Ab00147-1.1-VPB
| Anti-IL-4 [11B11]
| 100 mg
| Absolute Antibody
| ELISA; FC; in vivo; IHC
|
|
| Mouse
| Request Quotation
| Request
|
Ab00130-23.0
| Anti-DC-SIGNR [16E7]
| 200 ug
| Absolute Antibody
| FC; IHC
|
|
| Human
| Request Quotation
| Request
|
Ab01474-10.3-BT
| Anti-Advanced Glycation End Products (AGE), Methylgloxal (MG) [3D11]
| 1 mg
| Absolute Antibody
| ELISA; IHC; WB
|
|
| Human; Mouse; Rat
| Request Quotation
| Request
|
Ab00117-1.1-BT
| Anti-Factor H [OX23]
| 1 mg
| Absolute Antibody
| ELISA; WB; IP; block
|
|
| Human; Primate; Mouse
| Request Quotation
| Request
|
Ab04134-10.3-BT
| Anti-ALCAM [035-234]
| 1 mg
| Absolute Antibody
| FACS; ADCC
|
|
| Human
| Request Quotation
| Request
|
Ab00146-19.0-BT
| Anti-TNF alpha [cA2 (Infliximab)]
| 500 ug
| Absolute Antibody
| ELISA; in vivo; FC
|
|
| Human
| Request Quotation
| Request
|
Ab00126-16.0
| Anti-CD20 [10F381 (rituximab)]
| 50 ug
| Absolute Antibody
| FC
|
|
| Human; Rhesus Monkey; Cynomolgus Monkey
| Request Quotation
| Request
|
Ab00117-23.0-BT
| Anti-Factor H [OX23]
| 1 mg
| Absolute Antibody
| ELISA; WB; IP; block
|
|
| Human; Primate; Mouse
| Request Quotation
| Request
|
Ab00126-21.0-BT
| Anti-CD20 [10F381 (rituximab)]
| 500 ug
| Absolute Antibody
| FC
|
|
| Human; Rhesus Monkey; Cynomolgus Monkey
| Request Quotation
| Request
|
Ab00449-1.4-BT
| Anti-alpha 5 beta 1 Integrin [M200 (Volociximab)]
| 1 mg
| Absolute Antibody
| ELISA; FC; IF; Block; IHC
|
|
| Human
| Request Quotation
| Request
|
Ab00110-6.1-VPB
| Anti-CD134 [OX86]
| 100 mg
| Absolute Antibody
| FC; agonist; IF; ELISA
|
|
| Mouse
| Request Quotation
| Request
|
Ab00122-16.0
| Anti-CD3 epsilon [OKT-3 (muromonab)]
| 50 ug
| Absolute Antibody
| FC
|
|
| Human
| Request Quotation
| Request
|
Ab00141-2.0
| Anti-Lipopolysaccharide [WN1 222-5]
| 200 ug
| Absolute Antibody
| WB; IHC-P
|
|
| Gram-negative bacteria
| Request Quotation
| Request
|
Ab00133-23.0-BT
| Anti-EGFR [528]
| 1 mg
| Absolute Antibody
| IF; IHC-P; IP; NTRL; WB; FC
|
|
| Human
| Request Quotation
| Request
|
Ab00136-11.0-BT
| Anti-V5 epitope tag [SV5-P-K]
| 1 mg
| Absolute Antibody
| ELISA; IF; IHC-Fr; IP; RIA; WB
|
|
| Paramyxovirus Simian Virus 5
| Request Quotation
| Request
|
Ab00777-1.6
| Anti-alpha-2 integrin inserted-domain [2E10]
| 100 ug
| Absolute Antibody
| ELISA; FC
|
|
| Human
| Request Quotation
| Request
|
Ab00135-1.1-BT
| Anti-Beta-galactosidase [13R4]
| 1 mg
| Absolute Antibody
| WB; FC; negative control
|
|
| E. Coli
| Request Quotation
| Request
|
Ab00146-15.0-BT
| Anti-TNF alpha [cA2 (Infliximab)]
| 500 ug
| Absolute Antibody
| ELISA; in vivo; FC
|
|
| Human
| Request Quotation
| Request
|
Ab00130-1.1-BT
| Anti-DC-SIGNR [16E7]
| 1 mg
| Absolute Antibody
| FC; IHC
|
|
| Human
| Request Quotation
| Request
|
Ab00122-19.0-BT
| Anti-CD3 epsilon [OKT-3 (muromonab)]
| 500 ug
| Absolute Antibody
| FC
|
|
| Human
| Request Quotation
| Request
|
Ab00131-23.0-BT
| Anti-D-Dimer [3B6]
| 1 mg
| Absolute Antibody
| LFA (Collodial Gold); ELISA; Latex and RBC Agglu
|
|
| Human
| Request Quotation
| Request
|
Ab00135-12.1-BT
| Anti-Beta-galactosidase [13R4]
| 1 mg
| Absolute Antibody
| WB; FC; negative control
|
|
| E. Coli
| Request Quotation
| Request
|
Ab00132-13.12
| Anti-Der p 1, Der f 1 [4C1]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| House Dust Mite
| Request Quotation
| Request
|
Ab00123-24.1
| Anti-CD16/CD32 [2.4G2]
| 200 ug
| Absolute Antibody
| FC; IF; IP; IHC; Block
|
|
| Mouse
| Request Quotation
| Request
|
Ab00146-19.0
| Anti-TNF alpha [cA2 (Infliximab)]
| 50 ug
| Absolute Antibody
| ELISA; in vivo; FC
|
|
| Human
| Request Quotation
| Request
|
Ab00139-23.0
| Anti-IL-10 [JES3-9D7]
| 200 ug
| Absolute Antibody
| ELISA; ELISpot capture antibody; Cytokine Neutral
|
|
| Human; Baboon; Rhesus; Cynomolgus
| Request Quotation
| Request
|
Ab00135-22.0
| Anti-Beta-galactosidase [13R4]
| 200 ug
| Absolute Antibody
| WB; FC; negative control
|
|
| E. Coli
| Request Quotation
| Request
|
Ab02447-2.3-BT
| Anti-Alpha Actinin 4 [Ab01AA4]
| 1 mg
| Absolute Antibody
| ELISA; IHC; IP
|
|
| Human
| Request Quotation
| Request
|
Ab03147-10.3
| Anti-Alpha actin 1 [3G8C7A6]
| 200 ug
| Absolute Antibody
| ELISA; IHC-P
|
|
| Human
| Request Quotation
| Request
|